AIM: To establish a method detecting porcine endogenous retrovirus (PERV) in China experimental minipigs and to evaluate the safety of PERV in three individuals treated with bioartificial liver support systems based on porcine hepatocytes. METHODS: Porcine hepatocytes were isolated with two-stage perfusion method, then cultured in the bioreactor, which is separated by a semipermeable membrane (0.2 microm) from the lumen through which the patients' blood plasma was circulated. After post-hemoperfusion, patients' blood was obtained for screening. Additionally, samples of medium collected from both intraluminal and extraluminal compartments of the laboratory bioreactor and culture supernate in vitro was analyzed. The presence of viral sequences was estimated by polymerase chain reaction (PCR) and reverse transcriptase-polymerase chain reaction (RT-PCR). Finally, the infection of virus in the supernate of common culture was ascertained by exposure to the fetal liver cells. RESULTS: PERV-specific gag sequences were found in the porcine hepatocytes using RT-PCR. and were detected in all samples from the intraluminal, extraluminal samples and culture supernate. However, culture supernatant from primary porcine hepatocytes (cleared of cellular debris) failed to infect human fetal liver cells. Finally, RT-PCR detected no PERV infection was found in the blood samples obtained from three patients at various times post-hemoperfusion. CONCLUSION: The assays used are specific and sensitive, identified by second PCR. PERVs could be released from hepatocytes cultured in bioreactor without the stimulation of mitogen and could not be prevented by the hollow fiber semipermeable membrane, indicating the existence of PERV safety in extracorporeal bioartificial liver support system (EBLSS).
AIM: To establish a method detecting porcine endogenous retrovirus (PERV) in China experimental minipigs and to evaluate the safety of PERV in three individuals treated with bioartificial liver support systems based on porcine hepatocytes. METHODS:Porcine hepatocytes were isolated with two-stage perfusion method, then cultured in the bioreactor, which is separated by a semipermeable membrane (0.2 microm) from the lumen through which the patients' blood plasma was circulated. After post-hemoperfusion, patients' blood was obtained for screening. Additionally, samples of medium collected from both intraluminal and extraluminal compartments of the laboratory bioreactor and culture supernate in vitro was analyzed. The presence of viral sequences was estimated by polymerase chain reaction (PCR) and reverse transcriptase-polymerase chain reaction (RT-PCR). Finally, the infection of virus in the supernate of common culture was ascertained by exposure to the fetal liver cells. RESULTS:PERV-specific gag sequences were found in the porcine hepatocytes using RT-PCR. and were detected in all samples from the intraluminal, extraluminal samples and culture supernate. However, culture supernatant from primary porcine hepatocytes (cleared of cellular debris) failed to infect human fetal liver cells. Finally, RT-PCR detected no PERVinfection was found in the blood samples obtained from three patients at various times post-hemoperfusion. CONCLUSION: The assays used are specific and sensitive, identified by second PCR. PERVs could be released from hepatocytes cultured in bioreactor without the stimulation of mitogen and could not be prevented by the hollow fiber semipermeable membrane, indicating the existence of PERV safety in extracorporeal bioartificial liver support system (EBLSS).
Authors: M P Chenard-Neu; K Boudjema; J Bernuau; C Degott; J Belghiti; D Cherqui; V Costes; J Domergue; F Durand; J Erhard; B De Hemptinne; G Gubernatis; A Hadengue; J Kemnitz; M McCarthy; H Maschek; G Mentha; K Oldhafer; B Portmann; M Praet; J Ringers; X Rogiers; L Rubbia; S Schalm; J P Bellocq Journal: Hepatology Date: 1996-05 Impact factor: 17.425
Authors: E Morsiani; P Pazzi; A C Puviani; M Brogli; L Valieri; P Gorini; P Scoletta; E Marangoni; R Ragazzi; G Azzena; E Frazzoli; D Di Luca; E Cassai; G Lombardi; A Cavallari; S Faenza; A Pasetto; M Girardis; E Jovine; A D Pinna Journal: Int J Artif Organs Date: 2002-03 Impact factor: 1.595
Authors: Karim Boudjema; Philippe Bachellier; Philippe Wolf; Jean-Daniel Tempé; Daniel Jaeck Journal: World J Surg Date: 2001-12-21 Impact factor: 3.352
Authors: V Specke; H J Schuurman; R Plesker; C Coulibaly; M Ozel; G Langford; R Kurth; J Denner Journal: Transpl Immunol Date: 2002-05 Impact factor: 1.708
Authors: Markus Irgang; Igor M Sauer; Alexander Karlas; Katrin Zeilinger; Jörg C Gerlach; Reinhard Kurth; Peter Neuhaus; Joachim Denner Journal: J Clin Virol Date: 2003-10 Impact factor: 3.168
Authors: Clara T Nicolas; Raymond D Hickey; Harvey S Chen; Shennen A Mao; Manuela Lopera Higuita; Yujia Wang; Scott L Nyberg Journal: Stem Cells Date: 2016-10-02 Impact factor: 6.277
Authors: Magdalena C Kimsa; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Joanna Gola; Peter Nicholson; Krzysztof Lopata; Urszula Mazurek Journal: Viruses Date: 2014-05-13 Impact factor: 5.048